Effect of maternal-fetal disorders on lung maturation. I. Diabetes mellitus.
Amniotic fluid for fetal lung maturity studies was obtained from 287 healthy and 198 diabetic women. Classes of diabetes were as follows: Class A, 111; Class B, 58; Class C, 13; Class D, 11; Class F, 4; and Class R, 1. The regression lines representing the relationship of amniotic fluid lecithin phosphorus concentration to gestational age at amniocentesis in each of the groups of diabetic patients were not statistically different from those of the control subjects. Each of the diabetic patients was then matched with a control subject of the same race, sex of newborn infant, and gestational age at amniocentesis. The regression lines of the nonhypertensive, hypertensive, and all diabetics were not different from those of their respective matched control subjects. Also there was no difference in the proportion of mature lecithin phosphorus concentrations at different weeks between diabetic and normal women. The absence of a significant influence of diabetes on fetal lung maturation is probably due to improvement in diabetic control resulting in normalization of the fetal metabolic environment.
D000649:Amniocentesis; D000653:Amniotic Fluid / Q000378:metabolism; D001724:Birth Weight; D003920:Diabetes Mellitus / Q000145:classification; D005260:Female; D005325:Fetal Organ Maturity; D005865:Gestational Age; D006801:Humans; D008168:Lung / Q000196:embryology*; D010298:Parity; D010713:Phosphatidylcholines / Q000378:metabolism; D010758:Phosphorus / Q000032:analysis; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000196:embryology; D011254:Pregnancy in Diabetics / Q000196:embryology* / Q000378:metabolism; D012737:Sex Factors; D013223:Statistics as Topic
D010713:Phosphatidylcholines; D010758:Phosphorus